Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI-AVENTIS DEUTSCHLAND GMBH Frankfurt am Main DE
01 1Articaine hydrochloride
01 1Germany
01 1Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 2001-431 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2012-01-26
Type : Chemical
Substance Number : 1688
20
Sanofi-aventis Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Articaine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-431 - Rev 02
This Chemical Type CEP, issued on January 26, 2012, remains in force until July 22, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1688 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?
